Abstract
The aim of this manuscript is to discuss the use of some advances in immunotherapies for cancer from an ethical standpoint. The analysis will be restricted to the application of gene-editing technologies to adoptive T cell immunotherapy
Lingua originale | English |
---|---|
Titolo della pubblicazione ospite | Second Generation Cell and Gene-based Therapies |
Pagine | 581-595 |
Numero di pagine | 15 |
DOI | |
Stato di pubblicazione | Pubblicato - 2020 |
Keywords
- Adoptive T Cell Therapy
- Gene-Editing